Published in IBI on October 10, 2025, by Benjamin Wilkin
Complete the form to access the rest of the post and take a deeper look at the science and ideas behind the research.
Wilkin, B., (2025) Comparing Organoids and Patient-derived Xenograft Models for the Development of Antibody-drug Conjugates - Crown Bioscience. https://blog.crownbio.com/comparing-organoids-and-patient-derived-xenograft-models-for-the-development-of-antibody-drug-conjugates
Although many prostate tumors are detected while still localized, prostate cancer remains a major focus of oncology drug discovery because of its high…
Read more
New data from translational research groups, platform developers, and earlystage biotech teams point to a clear trend in 2026: scalable 3D assays and …
Read more
In the fast-paced world of translational oncology, pharmaceutical developers face a relentless challenge: how to move programs from the laboratory to …
Read more
